论文部分内容阅读
“泰乐抗癌增敏口服液”使BLM的抑瘤效应增强 6 0 %以上 ,联合治疗的S -180腹水小鼠存活时间比单独用BLM延长2 1%。以上结果提示“泰乐抗癌增敏口服液”在临床上有可能提高BLM的治癌效果
“Tale Anticancer Sensitizing Oral Solution” enhanced the tumor-inhibitory effect of BLM by more than 60%. The survival time of combined treatment of S-180 ascites mice was 21% longer than that of BLM alone. The above results suggest that “Tale anti-cancer sensitizing oral liquid” may increase the clinical efficacy of BLM cancer treatment